ArticleImmunotherapy advances2025

Development and evaluation of two whole-blood flow cytometry protocols for monitoring patients treated with JAK inhibitors.

Louis Waeckel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.